Department of Neurology, Medical University of Vienna, Vienna, Austria.
Department of Neurology, Wilhelminenspital, Vienna, Austria.
Int J Geriatr Psychiatry. 2019 Nov;34(11):1698-1705. doi: 10.1002/gps.5184. Epub 2019 Aug 6.
In the field of Parkinson disease (PD) research, many studies have shown that deep brain stimulation (DBS) can soften side effects, which arise during long-term medical therapy. This study focuses on the changes in depressive symptoms, quality of life (with the subdivisions physical and mental health), activities of daily living, and subjective memory functioning in PD patients testing the baseline and the outcome 1 year after DBS.
For the first time, the reliable change index (RCI) methodology was applied to compare PD-DBS patients (n = 22) with best medically treated PD patients (PD-BMT; n = 28), subjects with mild cognitive impairment (MCI, n = 43) and healthy controls (n = 25) in the above-mentioned domains. The used questionnaires included the revised Beck Depression Inventory (BDI-II), the Short Form (36) Health Survey (SF-36), the Bayer Activities of Daily Living Scale (B-ADL), and the Forgetfulness Assessment Inventory (FAI).
The reliable change indices show high constant or improved results of the PD-DBS patients in the domains subjective memory (85.7%-100.0%), activities of daily living (60.0%-90.0%), physical health summary (77.8%), depressive symptoms (61.9%), and mental health summary (50.0%) in comparison with the PD-BMT, MCI, and control group.
DBS is an established alternative to best medical treatment of PD. The comparisons between the PD-DBS and PD-BMT groups do suggest that the domains mental health, depressive symptoms, and physical health benefit most, while the domains activities of daily living and subjective memory functioning are rather constant. Nevertheless, further research is needed to identify mechanisms and predictors that lead to improvement in individual cases.
在帕金森病(PD)研究领域,许多研究表明,深部脑刺激(DBS)可以减轻长期药物治疗引起的副作用。本研究关注的是 PD 患者在 DBS 测试后的 1 年中,抑郁症状、生活质量(分为身心健康)、日常生活活动和主观记忆功能的变化。
首次应用可靠变化指数(RCI)方法,将 DBS 治疗的 PD 患者(n = 22)与最佳药物治疗的 PD 患者(PD-BMT;n = 28)、轻度认知障碍(MCI,n = 43)和健康对照组(n = 25)进行比较。使用的问卷包括修订后的贝克抑郁量表(BDI-II)、短表(36)健康调查(SF-36)、拜耳日常生活活动量表(B-ADL)和遗忘评估量表(FAI)。
可靠变化指数显示,与 PD-BMT、MCI 和对照组相比,PD-DBS 患者在主观记忆(85.7%-100.0%)、日常生活活动(60.0%-90.0%)、身体健康综合评分(77.8%)、抑郁症状(61.9%)和心理健康综合评分(50.0%)方面的结果保持或改善。
DBS 是 PD 最佳药物治疗的一种替代方法。PD-DBS 与 PD-BMT 组之间的比较表明,心理健康、抑郁症状和身体健康等领域受益最大,而日常生活活动和主观记忆功能等领域则相对稳定。然而,还需要进一步的研究来确定导致个别病例改善的机制和预测因素。